Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Weizmann Institute researchers reveal how Copaxone protects the heart muscle and improves its function after a heart attack
Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission
A preeminent scientist and the sixth President of the Weizmann Institute of Science
Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
One in every hundred adults in the Western world suffers from chronic glaucoma, a disease that causes blindness. Prof. Michal Schwartz,...
Institute scientists halt progressive eyesight loss in animals afflicted with a glaucoma-like disease